WGS GeneDx Holdings Earnings and EPS analysis

Relative Growth: Rel. Growth: 35

Relative Strength: Rel. Strength: 62

Relative Valuation: Rel. Valuation: 9

Relative Profitability: Rel. Profitability: 19

EPS in 2026 (TTM): -$3.64

Last Report Period Date: Jun 30, 2026

According to the most recent financial data from June 2026, the current EPS (TTM) is -$3.64. GeneDx Holdings's EPS for 2025 came in at -$0.73, marking an increase from -$1.94 in 2024. For the quarterly period ending on Jun 30, 2026, WGS's EPS was -$0.6.

WGS earnings history

Historical annual and quarterly earnings per share (EPS) data for GeneDx Holdings

EPS (TTM)

-$3.64

EPS Growth YoY (Quarterly)

-257.9%

EPS (Quarterly)

-$0.6

EPS Growth (Quarterly)

72.2%

GeneDx Holdings had an annual EPS of -$0.73, marking an increase of 62.4% from -$1.94 in 2024. The quarterly EPS for the period ending Jun 30, 2026, was -$0.6, marking a 257.9% decrease from the same quarter last year. WGS's TTM EPS stands at -$3.64 as of June 2026. GeneDx Holdings's EPS for 2024 stood at -$1.94, a 73.2% increase from 2023.

WGS EPS vs price chart

WGS EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

-257.9%

EPS growth YoY

62.4%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Over the last 12 months, GeneDx Holdings has registered an EPS growth of -257.9% (YoY, quarterly).

WGS Earnings Waterfall

Breakdown of revenue, profit and net income for GeneDx Holdings

WGS Earnings vs Peers

What are the earnings of WGS compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
NEOG Neogen Corp	N/A	99.2%	N/A	N/A
NTRA Natera Inc	N/A	0.7%	N/A	N/A
MYGN Myriad Genetics Inc	N/A	-180.1%	N/A	N/A
WGS GeneDx Holdings Corp	N/A	62.4%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.